glp 1 agonist schizophrenia GLP-1 Receptor Agonists Improve Metabolic Outcomes in Patients on Antipsychotics: JAMA GLP-1 drugs tied to lower
Description
The incidence of gastric food retention was 6.8% in the GLP-1RAs group compared to 1.7% in the non-GLP-1RAs group
85 , 89 Further prospective studies are needed to clarify perioperative risks associated with GLP-1 RA use and inform individualized management
CONTRAVE may cause serious side effects, including: Seizures
Most patients notice improved blood sugar control and changes in appetite within a few weeks
showed less pain, lower inflammation (CRP), and better cholesterol and blood pressure
